Grants and Contributions:
Title:
eVLP Production Technology Transfer and Initial Scale-Up of VBI-2901
Agreement Number:
953199
Agreement Value:
$1,000,000.00
Agreement Date:
Jun 26, 2020 - Dec 31, 2020
Description:
Conduct the production technology transfer and initial scale-up of the eVLP platform for VBI-2901.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1V 1C1
Reference Number:
172-2020-2021-Q2-953199
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
867258410
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days. Carleton 35088
Amendment Date
Oct 27, 2020
Recipient's Operating Name:
VBI Vaccines
Recipient's Legal Name:
Variation Biotechnologies Inc. (VBI)
Federal Riding Name:
Ottawa South
Federal Riding Number:
35077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: